Mapping the Genetic Architecture of Multiple Sclerosis Through Autoimmune Disease Overlap
Multiple sclerosis is a chronic immune-mediated disease in which inflammatory processes damage myelin and oligodendrocytes in the central nervous system, ultimately disrupting neurological function. The article “Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations” presents a large-scale genetic investigation designed to identify additional inherited risk factors for multiple sclerosis. Rather than treating multiple sclerosis as an isolated neurological disorder, the authors frame it within the wider biology of autoimmune disease, emphasizing that many susceptibility loci for multiple sclerosis implicate immune regulation more strongly than neuronal degeneration.
Combining Nordic Cohorts with International Genetic Data
The study used a meta-analytic strategy that combined publicly available summary statistics from a large international multiple sclerosis study with three Nordic cohorts from Iceland, Sweden, and Norway. In total, the analysis incorporated 21,079 cases and 371,198 controls, providing substantial statistical power to detect variants with modest effects. The authors performed two complementary analyses: one focused on Immunochip variants enriched for immune-related loci, and another based on imputed genome-wide data from the Nordic cohorts. This dual design allowed the researchers to exploit dense immune-region coverage while also searching beyond variants directly represented on the Immunochip.
Seven Novel Variants from Meta-Analysis
The first major result was the identification of seven sequence variants associated with multiple sclerosis that had not previously reached genome-wide significance in published genome-wide association studies. These variants included signals near or within genes such as MTHFR, LPP, NCOA2, CD6/CD5, ETS1, and DLEU-region loci. Particularly notable was rs1801133 in MTHFR, a missense variant that alters folate and homocysteine metabolism. Because methionine metabolism has been reported as dysregulated in multiple sclerosis brain tissue, this finding suggests a possible biochemical link between inherited variation, methylation-related pathways, and disease susceptibility.
Polygenic Risk Scores and Autoimmune Overlap
A central innovation of the study was its use of polygenic risk scores to quantify shared genetic architecture among autoimmune diseases. The authors constructed polygenic scores for several autoimmune conditions and tested whether genetic liability to one disease predicted risk of another in the Icelandic population. This analysis revealed clusters of autoimmune diseases broadly corresponding to seropositive and seronegative conditions, while multiple sclerosis and primary biliary cirrhosis occupied a distinctive position. The strongest cross-disease relationship observed for multiple sclerosis was with primary biliary cirrhosis, indicating that these two diseases share a meaningful component of inherited immune risk.
Primary Biliary Cirrhosis as a Proxy Phenotype
Building on this genetic correlation, the authors used primary biliary cirrhosis as a proxy phenotype for multiple sclerosis. The rationale was that variants contributing to primary biliary cirrhosis risk would have an increased prior probability of also influencing multiple sclerosis risk. By testing 255 variants that contributed to the primary biliary cirrhosis polygenic risk score, the researchers identified seven additional multiple sclerosis-associated variants that were not explained by previously established multiple sclerosis loci. This proxy-phenotype strategy demonstrates how genetic information from one disease can increase discovery power in another, especially when both disorders share immunological mechanisms.
Immune Signaling and Candidate Biological Mechanisms
Many of the newly identified variants point toward immune signaling pathways, especially those involved in cytokine responses and T-cell differentiation. A low-frequency missense variant in TYK2, rs35018800, was associated with protection against multiple sclerosis and showed the largest non-MHC effect reported by the authors among the newly discovered signals. Other variants implicated genes such as IL12RB2, TXK, IRF5-adjacent regions, and TEF, several of which are biologically plausible candidates in autoimmune pathogenesis. The IL12RB2 signal is especially relevant because IL-12 signaling contributes to differentiation of naïve T cells into Th1 cells, a pathway long associated with inflammatory immune responses.
Significance and Scientific Caution
This article is important because it expands the catalog of genetic variants associated with multiple sclerosis while also illustrating a broader methodological principle: genetic correlations between diseases can guide variant discovery. The fourteen reported variants explain only a modest fraction of disease liability, but their value lies in highlighting pathways that may contribute to disease onset and immune dysregulation. The authors appropriately note that several proxy-phenotype findings do not meet the conventional threshold for genome-wide significance and therefore require replication. Nevertheless, the study provides a rigorous example of how meta-analysis, polygenic risk modeling, and cross-disease genetics can be integrated to reveal new insights into complex autoimmune disease biology.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Olafsson, S., Stridh, P., Bos, S.D. et al. Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations. npj Genomic Med 2, 24 (2017). https://doi.org/10.1038/s41525-017-0027-2
